{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:32:13Z","timestamp":1789651933656,"version":"4.0.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116101","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T03:34:27Z","timestamp":1709955267000},"page":"116101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Quantification of endogenous Angiotensin 1-10, 1-9, 1-8, 1-7, and 1-5 in human plasma using micro-UHPLC-MS\/MS: Outlining the importance of the pre-analytics for reliable results"],"prefix":"10.1016","volume":"243","author":[{"given":"Jonathan","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9on","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grouzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Wuerzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J.","family":"Eugster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116101_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.jpba.2024.116101_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin-angiotensin-aldosterone system and its therapeutic targets","volume":"186","author":"Mirabito Colafella","year":"2019","journal-title":"Exp. Eye Res"},{"issue":"12","key":"10.1016\/j.jpba.2024.116101_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/CS20130436","article-title":"Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling","volume":"126","author":"McKinney","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.jpba.2024.116101_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/jcm9010267","article-title":"The vasoactive mas receptor in essential hypertension","volume":"9","author":"Povlsen","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpba.2024.116101_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.peptides.2016.09.009","article-title":"Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor","volume":"86","author":"Yu","year":"2016","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.jpba.2024.116101_bib6","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.cellsig.2014.06.011","article-title":"A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology","volume":"26","author":"Balakumar","year":"2014","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.jpba.2024.116101_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.jhh.1001960","article-title":"RAS inhibition in hypertension","volume":"20","author":"Ibrahim","year":"2006","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"10.1016\/j.jpba.2024.116101_bib8","first-page":"112","article-title":"The hypertension pandemic: an evolutionary perspective","volume":"32","author":"Rossier","year":"2017","journal-title":"Physiol. (Bethesda)"},{"issue":"6","key":"10.1016\/j.jpba.2024.116101_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ. Res"},{"issue":"9","key":"10.1016\/j.jpba.2024.116101_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11906-017-0771-9","article-title":"Effects of RAAS inhibitors in patients with kidney disease","volume":"19","author":"Zhang","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"issue":"3","key":"10.1016\/j.jpba.2024.116101_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther. Adv. Cardiovasc Dis."},{"issue":"2","key":"10.1016\/j.jpba.2024.116101_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jpba.2024.116101_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.8.6.476","article-title":"Specific measurement of angiotensin metabolites and in vitro generated Angiotensin II in plasma","author":"N\u00fcssberger","year":"1986","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.jpba.2024.116101_bib14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1515\/cclm-2017-0197","article-title":"Mass spectrometry or immunoassay: est modus in rebus","volume":"55","author":"Antonelli","year":"2017","journal-title":"Clin. Chem. Lab Med"},{"issue":"11","key":"10.1016\/j.jpba.2024.116101_bib15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/1522-2683(200206)23:11<1577::AID-ELPS1577>3.0.CO;2-4","article-title":"Separation and detection of angiotensin peptides by Cu(II) complexation and capillary electrophoresis with UV and electrochemical detection","volume":"23","author":"Lacher","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2024.116101_bib16","first-page":"39","article-title":"Recent advances in mass spectrometric and other analytical techniques for the identification of drug metabolites","author":"Castro-Perez","year":"2020","journal-title":"Identif. Quantif. Drugs, Metab., Drug Metab. Enzym.\u00a0Transp."},{"issue":"5","key":"10.1016\/j.jpba.2024.116101_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/00045632211008923","article-title":"An LC-MS\/MS assay for analysis of equilibrium angiotensin II in human serum","volume":"58","author":"Bernstone","year":"2021","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.jpba.2024.116101_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123943","article-title":"Development and validation of an LC-MS\/MS method for the simultaneous quantitation of angiotensin (1\u20137), (1\u20138), (1\u20139) and (1\u201310) in human plasma","volume":"1232","author":"Demeuse","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116101_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114327","article-title":"Robust analysis of angiotensin peptides in human plasma: column switching-parallel LC\/ESI-SRM\/MS without adsorption or enzymatic decomposition","volume":"630","author":"Suzuki","year":"2021","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jpba.2024.116101_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-022-01008-9","article-title":"Plasma angiotensin peptides as biomarkers of rheumatoid arthritis are correlated with anti-ACE2 auto-antibodies level and disease intensity","author":"Khajeh Pour","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jpba.2024.116101_bib21","unstructured":"Wai-Shan Lo, C., et al., Quantitation of plasma angiotensin II in healthy Chinese subjects by a validated liquid chromatography tandem mass spectrometry method. Biomedical Chromatography, 2022."},{"key":"10.1016\/j.jpba.2024.116101_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2014.06.072","article-title":"Strategies to reduce aspecific adsorption of peptides and proteins in liquid chromatography\u2013mass spectrometry based bioanalyses: an overview","volume":"1358","author":"Maes","year":"2014","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.jpba.2024.116101_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ab.2007.06.045","article-title":"Simultaneous analysis of angiotensin peptides by LC\u2013MS and LC\u2013MS\/MS: metabolism by bovine adrenal endothelial cells","volume":"369","author":"Cui","year":"2007","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.jpba.2024.116101_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1081\/CBI-100103969","article-title":"Cardiovascular regulation in TGR(mREN2)27 rats: 24h variation in plasma catecholamines, angiotensin peptides, and telemetric heart rate variability","volume":"18","author":"Schiffer","year":"2001","journal-title":"Chrono-.-. Int"},{"issue":"5","key":"10.1016\/j.jpba.2024.116101_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/hr.2016.166","article-title":"Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney","volume":"40","author":"Ohashi","year":"2017","journal-title":"Hypertens. Res"},{"key":"10.1016\/j.jpba.2024.116101_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.15314\/tsed.604845","article-title":"RAA system and exercise relationship","author":"Patlar","year":"2019","journal-title":"Turk. J. Sport Exerc."},{"issue":"1","key":"10.1016\/j.jpba.2024.116101_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11906-012-0319-y","article-title":"The \"his and hers\" of the renin-angiotensin system","volume":"15","author":"Hilliard","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.jpba.2024.116101_bib28","unstructured":"FDA, Guidance for Industry - Bioanalytical Method Validation, in: U.S.F.a.D. Administration. (Ed.) 2018."},{"key":"10.1016\/j.jpba.2024.116101_bib29","unstructured":"EMA, ICH guideline M10 on bioanalytical method validation and study sample analysis. (Ed.) 2022."},{"key":"10.1016\/j.jpba.2024.116101_bib30","unstructured":"CLSI, C64 Quantitative Measurement of Proteins and Peptides by Mass Spectrometry. (Ed.) 2021."},{"key":"10.1016\/j.jpba.2024.116101_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123904","article-title":"Tutorial review for peptide assays: an ounce of pre-analytics is worth a pound of cure","volume":"1229","author":"Maurer","year":"2023","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116101_bib32","doi-asserted-by":"crossref","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116101_bib33","unstructured":"Johnson, J.R., Methods for Handling Concentration Values Below the Limit of Quantification in PK Studies. PhUSE US Connect, 2018."},{"issue":"4","key":"10.1016\/j.jpba.2024.116101_bib34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/EJE-20-1445","article-title":"Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19","volume":"184","author":"Kutz","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.jpba.2024.116101_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00114-2021","article-title":"Increased circulating levels of angiotensin-(1-7) in severely ill COVID-19 patients","volume":"7","author":"Valle Martins","year":"2021","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.jpba.2024.116101_bib36","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.119.13982","article-title":"IL (Interleukin)-1 receptor antagonist increases Ang (Angiotensin [1\u20137]) and decreases blood pressure in obese individuals","volume":"75","author":"Urwyler","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.jpba.2024.116101_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"Roles of angiotensin peptides and recombinant human ACE2 in heart failure","volume":"69","author":"Basu","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jpba.2024.116101_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-4347(99)00128-0","article-title":"Determination of angiotensin metabolites in human plasma by fluorimetric high-performance liquid chromatography using a heart-cut column-switching technique","author":"Matsui","year":"1999","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116101_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122740","article-title":"A liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma","volume":"1179","author":"Chen","year":"2021","journal-title":"J. Chromatogr. B"},{"issue":"13","key":"10.1016\/j.jpba.2024.116101_bib40","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/jssc.201801276","article-title":"Simultaneous determination of nine trace concentration angiotensin peptides in human serum using ultra high performance liquid chromatography with tandem mass spectrometry with sephadex LH-20 gel solid-phase extraction","volume":"42","author":"Shen","year":"2019","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2024.116101_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/00004872-199002000-00011","article-title":"Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man","author":"Campbell","year":"1990","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jpba.2024.116101_bib42","article-title":"Influence of gender and genetic variability on plasma angiotensin peptides","author":"Reyes-Engel","year":"2006","journal-title":"JRAAS"},{"key":"10.1016\/j.jpba.2024.116101_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221122544","article-title":"The prognostic importance of the angiotensin II\/angiotensin-(1-7) ratio in patients with SARS-CoV-2 infection","volume":"16","author":"Amezcua-Guerra","year":"2022","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"3","key":"10.1016\/j.jpba.2024.116101_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1470320314523659","article-title":"Renin-angiotensin-aldosterone system gender differences in an Afro-Caribbean population","volume":"16","author":"Cohall","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"6","key":"10.1016\/j.jpba.2024.116101_bib45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1753944713513221","article-title":"Hemodynamic and hormonal patterns of untreated essential hypertension in men and women","volume":"7","author":"Ferrario","year":"2013","journal-title":"Ther. Adv. Cardiovasc Dis."},{"key":"10.1016\/j.jpba.2024.116101_bib46","article-title":"The road to reliable peptide assays is paved with good guidelines","author":"Maurer","year":"2022","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.jpba.2024.116101_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/clinchem\/hvac037","article-title":"LC-MS\/MS peptide assay validation: a plea for robust stability studies","volume":"68","author":"Grouzmann","year":"2022","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2024.116101_bib48","doi-asserted-by":"crossref","first-page":"H454","DOI":"10.1152\/ajpheart.00960.2015","article-title":"Reply to \"Letter to the editor: angiotensin quantification by mass spectrometry\"","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"30","key":"10.1016\/j.jpba.2024.116101_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-019-02162-w","article-title":"Letter to the Editor regarding \u201cA microanalytical capillary electrophoresis mass spectrometry assay for quantifying angiotensin peptides in the brain\u201d","volume":"411","author":"Danser","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2024.116101_bib50","doi-asserted-by":"crossref","first-page":"H452","DOI":"10.1152\/ajpheart.00933.2015","article-title":"Letter to the editor: angiotensin quantification by mass spectrometry","volume":"310","author":"Poglitsch","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.jpba.2024.116101_bib51","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.jpba.2024.116101_bib52","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/HYPERTENSIONAHA.120.16724","article-title":"Concerns on the specificity of commercial ELISAs for the measurement of Angiotensin (1-7) and Angiotensin II in human plasma","volume":"77","author":"Chappell","year":"2021","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.jpba.2024.116101_bib53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00216-003-2298-y","article-title":"Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry","volume":"378","author":"Harald","year":"2004","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T20:05:18Z","timestamp":1715285118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":53,"alternative-id":["S0731708524001419"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116101","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of endogenous Angiotensin 1-10, 1-9, 1-8, 1-7, and 1-5 in human plasma using micro-UHPLC-MS\/MS: Outlining the importance of the pre-analytics for reliable results","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116101"}}